Aspire BioPharma, Inc. (ASBP) — Defensive Interval Ratio

Latest as of March 2025: 2 days

Aspire BioPharma, Inc. (ASBP) has a Defensive Interval Ratio of 2 days as of March 2025. Defensive assets of $36.50K (cash $-, short-term investments $-, receivables $36.50K) cover 2 days of daily cash needs of $24.30K/day. See ASBP working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Defensive Interval Ratio

2 days
Days of operational coverage

Defensive Assets

$36.50K
Cash + ST Investments + Receivables

Daily Cash Need

$24.30K
Current Liabilities ÷ 365

Current Liabilities

$8.87 Million
USD

Aspire BioPharma, Inc. Defensive Interval Ratio (2024–2024)

This chart shows how Aspire BioPharma, Inc.'s Defensive Interval Ratio has evolved across 1 annual periods from 2024 to 2024. As of March 2025, the ratio stands at 2 days, meaning defensive assets of $36.50K can fund 2 days of operations without new revenue. See Aspire BioPharma, Inc. (ASBP) net asset quality to measure how much of total assets are equity-financed.

Annual Defensive Interval Ratio for Aspire BioPharma, Inc. (2024–2024)

The table below presents the year-by-year Defensive Interval Ratio for Aspire BioPharma, Inc. from 2024 to 2024, covering 1 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Aspire BioPharma, Inc. (ASBP) market capitalisation.

Year DIR (days) Defensive Assets (USD) Daily Cash Need Cash ST Investments Change (days)
2024 8 days $36.50K $4.62K/day $- $-
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)